Darren Orton, Ph.D.

Dr. Darren Orton is the Director of Medicinal Chemistry at SSTI. He has over 20 years of experience in all phases of drug discovery and development. Prior to joining SSTI, he was at Vanderbilt University, where he specialized in early lead discovery, high-throughput screening and molecular modeling. At Albany Molecular Research, he was part of a team that collaborated with Bristol-Myers Squibb to take BMS708163 (a Gamma-Secretase inhibitor) into clinical trials. Dr. Orton received his Ph.D. degree at the University of Durham in organic chemistry, working on the synthesis of natural products. He completed an industrial placement year in medicinal chemistry at Sanofi in the United Kingdom.